09:30 Registration, coffee
10:00 Welcome & Opening
10:05 Huub Schellekens, University of Utrecht
Title to be submitted
10:50 Reed Harris, Genentech Inc. South San Francisco, CA, USA
Comparability Assessment Strategies and Techniques for Post-Approval CMC Changes
11:35 Andreas Seidl, Novartis/Sandoz
Title to be submitted
12:20 Lunch & Poster session
13:15 Henno van den Hooven, Schering-Plough, Oss
Analytical assessment of biotech product quality
13:55 Claudia Berger, Solvay, Germany
Oral recombinant enzyme replacement therapy: DMPK and Immunogenicity Assessment (A Case Study)
14:35 Joseph Marini, Centocor, Radnor, PA, USA
Title to be submitted
15:15 Meena Subramanyan, Biogen Idec, Boston, MA, USA
Title to be submitted
16.00 Closure & Farewell drink
Monday, October 6, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment